Lenny Rachitsky and a16zftr
Dan Runcie and a16zftr
Sonal Chokshi, Chris Dixon, Denis Nazarov, Jesse Walden, and Linda Xie
Anu Hariharan and a16zftr
Peter Yang
We discuss a new class of drugs that, in essence, toss specific disease-related proteins into the cellular trash can.
Aging research is entering a new phase. How is studying aging helping us understand disease and increasing the amount of time we are healthy?
Can we improve the processes of photosynthesis and carbon fixation to one day increase crop growth and carbon sequestration in plants?
A short but deep dive on the opioid crisis: How do opioids work? Who's to blame? What are other directions for managing pain?
Building a software company in healthcare is hard — and comes along with unique challenges no other entrepreneurs face. Here's what builders need to know.
The black box in AI isn’t a new problem due to new tech: Human intelligence itself is — and always has been — a black box.
What does AI in medicine look like, practically speaking, whether it's ensuring the best data, versioning software for healthcare, or other aspects?
What it will take to make a Jurassic Park-like story come true, and what motivates seemingly crazy ideas.
What happens when our body parts no longer have to be physically co-located? What's possible, probable, pressing when man becomes god, or merges with machines?